We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts interested in joining the connect are requested to complete the registration on link provided in the attached intimation by June 8, 2026. The company will share meeting link and details to the participants who have registered, separately.
Please find attached signed Annual Secretarial Compliance report for the year ended March 31, 2026
Record date for purpose of dividend
Board has recommended final dividend for the Financial Year 2025-26, subject to approval of shareholders.
Please find attached press release for the quarter and financial year ended March 31, 2026.
Dear Sir, Please find attached intimation for re appointment of Independent Director.
Dear Sir, Please find attached audited financial results for the year ended March 31, 2026.
We are enclosing herewith the following: a. Audited Financial Results for the Financial Year ended March 31, 2026, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor’s Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a dividend of Rs. 45 per Equity Share (Nominal Value of Rs. 10/- each), for the Financial Year ended March 31, 2026. The divided shall be paid on or before September 25, 2026, on approval of the Members at the ensuing Annual General Meeting.
Dear Sir, Please find attached our intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015. Request you to kindly take the same on record.
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyProcter & Gamble Health Ltd 2CIN NO.L99999MH1967PLC013726 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ZEAL RUPANI Designation: Company Secretary EmailId: SHAH.ZS@PG.COM Name of the Chief Financial Officer: SHASHANK SROWTHY Designation: CFO Director EmailId: srowthy.sr@pg.com Date: 06/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.